75 related articles for article (PubMed ID: 16257851)
1. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.
Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Savina PM; Santostefano MJ
Int J Toxicol; 2005; 24(5):313-25. PubMed ID: 16257851
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.
Nesfield SR; Clarke CJ; Hoivik DJ; Miller RT; Allen JS; Selinger K; Santostefano MJ
Int J Toxicol; 2005; 24(5):301-11. PubMed ID: 16257850
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.
Torrey CE; Campbell JA; Hoivik DJ; Miller RT; Allen JS; Mann PC; Selinger K; Rickert D; Savina PM; Santostefano MJ
Int J Toxicol; 2005; 24(5):289-99. PubMed ID: 16257849
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.
Nesfield SR; Williams TC; Hoivik DJ; Miller RT; Allen JS; Selinger K; Rickert D; Santostefano MJ
Int J Toxicol; 2005; 24(5):341-8. PubMed ID: 16257853
[TBL] [Abstract][Full Text] [Related]
6. Investigations of clofibrate in alternative carcinogenicity models.
Santostefano MJ; Hoivik DJ; Miller RT
Int J Toxicol; 2005; 24(5):285-8. PubMed ID: 16257848
[No Abstract] [Full Text] [Related]
7. Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice.
Doi AM; Hailey JR; Hejtmancik M; Toft JD; Vallant M; Chhabra RS
Toxicol Pathol; 2005; 33(6):631-40. PubMed ID: 16176922
[TBL] [Abstract][Full Text] [Related]
8. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
9. 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.
Cho WS; Jeong J; Choi M; Park SN; Han BS; Son WC
Arch Toxicol; 2011 Jan; 85(1):59-66. PubMed ID: 20358181
[TBL] [Abstract][Full Text] [Related]
10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic studies in Tg.AC and FVB mice administered [14C] benzene either by oral gavage or intradermal injection.
Hoffmann MJ; Sinko PJ; Lee YH; Meeker RJ; Snyder R
Toxicol Appl Pharmacol; 2001 Jul; 174(2):139-45. PubMed ID: 11446829
[TBL] [Abstract][Full Text] [Related]
12. Tg.AC genetically altered mouse: assay working group overview of available data.
Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
[TBL] [Abstract][Full Text] [Related]
13. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study.
Toyosawa K; Okimoto K; Kobayashi I; Kijima K; Kikawa E; Kohchi M; Koujitani T; Tanaka K; Matsuoka N
Toxicol Pathol; 2001; 29(4):458-66. PubMed ID: 11560251
[TBL] [Abstract][Full Text] [Related]
14. Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.
Hoivik DJ; Allen JS; Wall HG; Nold JB; Miller RT; Santostefano MJ
Int J Toxicol; 2005; 24(5):349-56. PubMed ID: 16257854
[TBL] [Abstract][Full Text] [Related]
15. Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice.
Arnold LL; Eldan M; Nyska A; van Gemert M; Cohen SM
Toxicology; 2006 Jun; 223(1-2):82-100. PubMed ID: 16677751
[TBL] [Abstract][Full Text] [Related]
16. 26-Week dermal oncogenicity study evaluating pure trans-capsaicin in Tg.AC hemizygous mice (FBV/N).
Chanda S; Erexson G; Frost D; Babbar S; Burlew JA; Bley K
Int J Toxicol; 2007; 26(2):123-33. PubMed ID: 17454252
[TBL] [Abstract][Full Text] [Related]
17. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate.
Kramer JA; Blomme EA; Bunch RT; Davila JC; Jackson CJ; Jones PF; Kolaja KL; Curtiss SW
Toxicol Pathol; 2003; 31(4):417-31. PubMed ID: 12851107
[TBL] [Abstract][Full Text] [Related]
18. Hepatic drug metabolizing enzymes induced by clofibrate in rasH2 mice.
Katsutani N; Sekido T; Aoki T; Sagami F
Toxicol Lett; 2000 Jun; 115(3):223-9. PubMed ID: 10814892
[TBL] [Abstract][Full Text] [Related]
19. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes and gene ontology processes critical to skin papilloma development in Tg.AC transgenic mice.
Dang H; Trempus C; Malarkey DE; Wei SJ; Humble M; Morris RJ; Tennant RW
Mol Carcinog; 2006 Feb; 45(2):126-40. PubMed ID: 16329151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]